Literature DB >> 27903740

Protective T Cell Responses Featured by Concordant Recognition of Middle East Respiratory Syndrome Coronavirus-Derived CD8+ T Cell Epitopes and Host MHC.

William J Liu1,2, Jiaming Lan2,3, Kefang Liu1,2, Yao Deng2, Yanfeng Yao4, Shaolian Wu5, Hong Chen2, Lingling Bao4, Haifeng Zhang1, Min Zhao6, Qihui Wang6, Lingxia Han5, Yan Chai6, Jianxun Qi6, Jincun Zhao7, Songdong Meng6, Chuan Qin4, George F Gao8,2,6,9, Wenjie Tan8,2.   

Abstract

The coordinated recognition of virus-derived T cell epitopes and MHC molecules by T cells plays a pivotal role in cellular immunity-mediated virus clearance. It has been demonstrated that the conformation of MHC class I (MHC I) molecules can be adjusted by the presented peptide, which impacts T cell activation. However, it is still largely unknown whether the conformational shift of MHC I influences the protective effect of virus-specific T cells. In this study, utilizing the Middle East respiratory syndrome coronavirus-infected mouse model, we observed that through the unusual secondary anchor Ile5, a CD8+ T cell epitope drove the conformational fit of Trp73 on the α1 helix of murine MHC I H-2Kd In vitro renaturation and circular dichroism assays indicated that this shift of the structure did not influence the peptide/MHC I binding affinity. Nevertheless, the T cell recognition and the protective effect of the peptide diminished when we made an Ile to Ala mutation at position 5 of the original peptide. The molecular bases of the concordant recognition of T cell epitopes and host MHC-dependent protection were demonstrated through both crystal structure determination and tetramer staining using the peptide-MHC complex. Our results indicate a coordinated MHC I/peptide interaction mechanism and provide a beneficial reference for T cell-oriented vaccine development against emerging viruses such as Middle East respiratory syndrome coronavirus.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27903740     DOI: 10.4049/jimmunol.1601542

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

1.  Strict Assembly Restriction of Peptides from Rabbit Hemorrhagic Disease Virus Presented by Rabbit Major Histocompatibility Complex Class I Molecule RLA-A1.

Authors:  Qingxu Zhang; Kefang Liu; Can Yue; Di Zhang; Dan Lu; Wenling Xiao; Peipei Liu; Yingze Zhao; Guolan Gao; Chunming Ding; Jianxin Lyu; William J Liu
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

2.  MHC-restricted Ag85B-specific CD8+ T cells are enhanced by recombinant BCG prime and DNA boost immunization in mice.

Authors:  Shihoko Komine-Aizawa; Jiansheng Jiang; Satoru Mizuno; Satoshi Hayakawa; Kazuhiro Matsuo; Lisa F Boyd; David H Margulies; Mitsuo Honda
Journal:  Eur J Immunol       Date:  2019-06-19       Impact factor: 5.532

3.  Increased Pathogenicity and Virulence of Middle East Respiratory Syndrome Coronavirus Clade B In Vitro and In Vivo.

Authors:  Yanqun Wang; Jing Sun; Xiaobo Li; Airu Zhu; Wenda Guan; De-Qiang Sun; Jingxian Zhao; Jicheng Huang; Jincun Zhao; Mian Gan; Xuefeng Niu; Jun Dai; Lu Zhang; Zhaoyong Zhang; Yongxia Shi; Shuxiang Huang; Chris Ka Pun Mok; Zifeng Yang; Zhongfang Wang; Wenjie Tan; Yimin Li; Ling Chen; Rongchang Chen; Malik Peiris; Nanshan Zhong
Journal:  J Virol       Date:  2020-07-16       Impact factor: 5.103

Review 4.  The COVID-19 Vaccine Landscape.

Authors:  Till Koch; Anahita Fathi; Marylyn M Addo
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  Coronaviruses in humans and animals: the role of bats in viral evolution.

Authors:  Amr El-Sayed; Mohamed Kamel
Journal:  Environ Sci Pollut Res Int       Date:  2021-03-02       Impact factor: 5.190

6.  N-glycosylation of PD-1 promotes binding of camrelizumab.

Authors:  Kefang Liu; Shuguang Tan; Wanjun Jin; Jiawei Guan; Qingling Wang; Huan Sun; Jianxun Qi; Jinghua Yan; Yan Chai; Zhongfu Wang; Chuxia Deng; George F Gao
Journal:  EMBO Rep       Date:  2020-10-15       Impact factor: 9.071

7.  CD8+ T Cells Responding to the Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Delivered by Vaccinia Virus MVA in Mice.

Authors:  Svenja Veit; Sylvia Jany; Robert Fux; Gerd Sutter; Asisa Volz
Journal:  Viruses       Date:  2018-12-16       Impact factor: 5.048

8.  Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus.

Authors:  Yao Deng; Jiaming Lan; Linlin Bao; Baoying Huang; Fei Ye; Yingzhu Chen; Yanfeng Yao; Wenling Wang; Chuan Qin; Wenjie Tan
Journal:  Emerg Microbes Infect       Date:  2018-04-04       Impact factor: 7.163

Review 9.  Novel therapeutic approaches for treatment of COVID-19.

Authors:  Nikoo Hossein-Khannazer; Bahare Shokoohian; Anastasia Shpichka; Hamid Asadzadeh Aghdaei; Peter Timashev; Massoud Vosough
Journal:  J Mol Med (Berl)       Date:  2020-06-03       Impact factor: 5.606

10.  Heterosubtypic Protections against Human-Infecting Avian Influenza Viruses Correlate to Biased Cross-T-Cell Responses.

Authors:  Min Zhao; Kefang Liu; Jiejian Luo; Shuguang Tan; Chuansong Quan; Shuijun Zhang; Yan Chai; Jianxun Qi; Yan Li; Yuhai Bi; Haixia Xiao; Gary Wong; Jianfang Zhou; Taijiao Jiang; Wenjun Liu; Hongjie Yu; Jinghua Yan; Yingxia Liu; Yuelong Shu; Guizhen Wu; Aiping Wu; George F Gao; William J Liu
Journal:  mBio       Date:  2018-08-07       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.